Gregory H. Corsan, MD, FACOG Bibliography

• Corsan GH, MacDonald PC, Casey, ML: Origin of deoxycorticosterone sulfate (DOC-SO4) in plasma of pregnant women: pregnenolone-3,21-disulfate is a placental precursor of DOC-SO4. J Steroid Biochem Mol Biol Mar;60(5-6):331-7, 1997.
• Corsan GH, Trias A, Trout S, Kemmann E: Superovulation combined with intrauterine insemination in women 40 years of age and older: is it worthwhile? Hum Reprod, 11, 5:1109- 1112, 1996.
• Karacan M, Shelden R, Corsan GH: Effect of 6-day workweek on cycle fecundity rates in controlled ovarian hyperstimulation-intrauterine insemination (COH-IUI) cycles in subfertile couples. J Reprod Med 41:767-771, 1996.
• Corsan GH, Karacan M, Qasim S, Bohrer M, Ransom MX, and Kemmann E: Identification of hormonal parameters for successful single-dose methotrexate therapy in ectopic pregnancy. Hum Reprod 10:2719-2722, 1995.
• Qasim SM, Karacan M, Corsan GH, Shelden R, Kemmann E: High- order oocyte transfer in gamete intrafallopian transfer patients 40 or more years of age. Fertil Steril 64:107-110, 1995.
• Corsan GH, Jow W, Qasim S, Karacan M: Laparoscopic gonadectomy in complete androgen insensitivity syndrome. J Am Assoc Gyn Laparoscopists; 2:87-89, 1994 .
• Ransom MX, Garcia AJ, Bohrer M, Corsan GH, Kemmann E: Serum progesterone as a predictor of methotrexate success in the treatment of ectopic pregnancy. Obstet Gynecol 83:1033, 1994.
• Ransom M, Corsan GH, Garcia AJ, Doherty KA, Kemmann E: Tubal selection for gamete intrafallopian transfer. Fertil Steril 61:386, 1994.
• Ransom M, Blotner M, Bohrer M, Corsan GH, Kemmann E: Does increasing frequency of intrauterine inseminations improve cycle fecundity significantly during superovulation cycles? Fertil Steril 61:303, 1994.
• Corsan GH, Blotner MB, Bohrer MK, Shelden R, Kemmann E: The utility of a home urinary luteinizing hormone immunoassay in timing the postcoital test. Obstet Gynecol 81:5, 1993.
• Corsan GH, Kemmann E, Bohrer, M, Blotner M, Smilow P, Shelden R: Use of urinary luteinizing hormone immunoassays in the assessment of luteal function in infertile women. Am J Obstet Gynecol 166:41, 1992.
• Corsan, GH, Kemmann E: Gonadotropin-releasing hormone agonist in a GIFT Program. New Jersey Med 89:275, 1992.
• Corsan GH: Conn's Current Therapy: 1993. Ectopic pregnancy. Rakel, ed. W.B. Saunders Co., p 998, 1993.
• Kemmann E, Ghazi D, Corsan GH, Bohrer MK: Post-operative observation versus ovulation stimulation in patients with minimal/mild endometriosis treated by laser laparoscopy. Int J Fertil, 38(1):16-21, 1993.
• Corsan GH, Kemmann E: The role of superovulation with menotropins in ovulatory infertility: a review. Fertil Steril, 55:468, 1990.
• Corsan GH, Kemmann E: Risk of a second consecutive first-trimester spontaneous abortion in women who conceive with menotropins. Fertil Steril 53:817, 1990.
• Kemmann E, Ghazi D, Corsan GH: Adnexal torsion in menotropin-induced pregnancies. Obstet Gynecol, 76:403, 1990.
• Corsan GH, Ghazi D, Kemmann E: Home urinary luteinizing hormone (LH) immunoassays: clinical applications. Fertil Steril 53:591, 1990.
• Corsan GH, Nezhat F: Tuboovarian abscess resulting in loss of a kidney. A case report. Am J Gynecol Health 3:1, 1989.
• Corsan GH, Kemmann E, Shelden R: Multiple gestation with intrauterine insemination and menotropin therapy. (Letter) Am J Obstet Gynecol 161:1751, 1989.
• Corsan GH, Kemmann E: Role of repetitive hCG injections during the luteal phase in stimulated cycles. Letters-to-the-editor, Fertil Steril 51:549, 1989.
• Corsan GH, Carr BR: Expectant management of ectopics. Letters-to-the-Editor, Fertil Steril 50:380, 1988.

• Trout S, Qasim S, Corsan G, Kemmann E: A prospective randomized study comparing fallopian sperm perfusion and intrauterine insemination. Presented at the 52nd Annual Meeting of the American Society of Reproductive Medicine, Boston, MA, November 1996.
• I El-Danasouri, S Trout, M Bohrer, G Corsan, R Sachdev, D Arbit, R Shelden, E Kemmann: Factors affecting the outcome of intracytoplasmic sperm injection. Presented at the 12th Annual Meeting of the European Society of Human Reproduction and Embryology, Maastricht, the Netherlands, June 30-July 3, 1996.
• I El-Danasouri, M Bohrer, G Corsan, R Sachdev, E Kemmann: Female chronological age determines the implantation rate during intracytoplasmic sperm injection. Presented at the Third World Conference on Early Pregnancy, Atlantic City, NJ, October, 1996.
• Trout S, Bohrer M, Corsan G, Sachdev R, Kemmann E: Is it worthwhile to perform intrauterine inseminations of less than one million motile sperm? Presented at the 51st Annual meeting of the American Society for Reproductive Medicine, Seattle, Washington, October 7-12, 1995.
• Karacan M, Qasim S, Corsan GH, Bohrer M, Kemmann E: Prediction of success of single-dose methotrexate (MTX) therapy in ectopic pregnancy (EP). Presented at the 50th Annual Meeting of The American Fertility Society, San Antonio, Texas, Nov. 1994.
• Shelden R, Kemmann E, Karacan M, Corsan G: Effect of 6-day work week on fecundity for controlled ovarian hyperstimulation-intrauterine insemination in subfertile couples. Presented at the Second World Conference on Implantation and Early Pregnancy in Humans, Atlantic City, May 1994.
• Ransom MX, Blotner MB, Bohrer M, Corsan GH, Shelden R, Cody R, Kemmann E: Cycle day 3 follicle-stimulating hormone (FSH) as a predictor of superovulation cycle performance. Presented at the 48th Annual Meeting of The American Fertility Society, New Orleans, LA, Dec. 1992.
• Corsan GH, Kemmann E: Experience with the use of sequential clomiphene ctrate/human menopausal gonadotropin therapy (CC/hMG) in infertility women. Presented at the 47th Annual Meeting of The American Fertility Society, Orlando, Florida, Nov. 1991.
• Corsan GH, Kemmann E, Blotner M, Bohrer M, Shelden R: The utility of urinary luteinizing hormone (LH) immunoassays in the performance of the postcoital test. Presented at the 47th Annual Meeting of The American Fertility Society, Orlando, Florida, Nov. 1991.
• Corsan GH, Smilow P, Shelden R, Kemmann E: Use of urinary luteinizing hormone immunoassays in the assessment of luteal function. Presented at the 46th Annual Meeting of The American Fertility Society, Washington, D.C., October, 1990.
• Corsan GH, Kemmann E: Risk of a second consecutive spontaneous abortion in human menopausal gonadotropin/human chorionic gonadotropin (hMG/hCG) cycles. Presented at the 45th Annual Meeting of The American Fertility Society, San Francisco, CA 1989.
• Corsan GH, Casey ML, MacDonald PC: The Origin of Deoxycorticosterone Sulfate (DOC-S04) in Plasma of Pregnant Women: Pregnenolone Sulfate as a Precursor. Proceedings of The Endocrine Society, p. 30, 1988 (abstract and slide presentation).
• Corsan GH, Casey ML, MacDonald PC: The Origin of Deoxycorticosterone Sulfate (DOC-S04) in Maternal Plasma: Fetal Plasma Pregnenolone-3, 21-Disulfate As a Placental Precursor of DOC-S04. Proceedings of The Society of Gynecological Investigation, p. 232, 1988.
• Byrd W, Carr BR, Corsan GH, et al: Artificial Insemination Using Frozen Donor Semen: A Randomized Study Comparing Intracervical and Intrauterine Insemination. 44th Annual Meeting of The American Fertility Society, October 10-13, p. S7, 1988.